Avenova Successfully Brings Relief to Patient with Challenging and Painful Eyelid Disease

In an article in Ophthalmic Professional, Delray’s Dr. Steven I. Rosenfeld describes how a new eyelid cleanser solved one patient’s chronic problems—and offers hope for many others

DELRAY BEACH, Fla.--()--Delray Eye Associates announced today that Delray ophthalmologist Steven I Rosenfeld, MD, FACS, who specializes in medical and surgical treatments of corneal conditions, infectious and inflammatory eye diseases, has written an article in Ophthalmic Professional describing how a new eyelid and lash hygiene product called Avenova successfully managed the eyelid disease of a particularly challenging patient.

As Dr. Rosenfeld describes, the 68-year-old man had suffered from constant and chronic symptoms of dry eyes, redness, tearing, intermittent foreign body sensation, and sharp shooting pains for more than two years. The patient had tried eye drops, ointments, baby shampoo, tea tree oil and a variety of eye scrubs. He had even seen eight other ophthalmologists before coming into Dr. Rosenfeld’s office. Despite all that, “…the patient said he failed to gain relief,” Dr. Rosenfeld writes. In fact, previous treatments had made his vision blurry and made him feel even worse.

Dr. Rosenfeld’s examination showed the man had chronic blepharitis, a condition typically caused by bacteria growing on the eyelids, resulting in redness, inflammation, pain and a crusty build-up. The man’s meibomian glands were also plugged, preventing the oily substance produced by the glands from reaching the tear film on the eye. That oily substance is crucial, since it prevents the tears from evaporating and making the eye dry. Moreover, his eyelashes were also turned inward, a condition called trichiasis, along with other conditions.

Dr. Rosenfeld prescribed the use of Avenova once a day. The product is very easy to use. Patients spray it onto a cotton pad and wipe their eyelids and lashes.

It worked. Within two weeks of daily use “…the patient felt much better and progressed with each subsequent visit,” Dr. Rosenfeld reports. And when last examined, two months after the treatment started, “…he was very pleased with the comfort of the lid scrub system, and the treatment effectively controlled the symptoms of the patient’s lid margin disease…. Avenova has helped me to make this patient comfortable,” Dr. Rosenfeld writes.

In the article, Dr. Rosenfeld also describes the science behind Avenova. It contains what manufacturer NovaBay Pharmaceuticals (NYSE MKT:NBY) calls Neutrox, the company’s proprietary, pure hypochlorous acid (HOCl). Lab tests show that, in solution, it rapidly eradicates 20 species of pathogens, including antibiotic-resistant Staphylococcus aureus. “This rapid killing of microorganisms helps prevent harmful biofilms from forming,” Dr. Rosenfeld explains. “In addition, Neutrox in vitro inactivates bacterial toxins that can cause inflammation.” Plus, it is completely safe and refreshing to use, patients report.

Dr. Rosenfeld concludes that Avenova should be used for the management of many eyelid diseases and conditions, not just for challenging patients like the one described in the article. “I would recommend Avenova for any lid hygiene regimen, including dry eye, blepharitis, ocular surgery and contact lens wear,” concludes Dr. Rosenfeld.

Contacts

Delray Eye Associates, PA
Steven I. Rosenfeld, M.D., 561-498-8100
16201 Military Trail
Delray Beach, FL 33484

Contacts

Delray Eye Associates, PA
Steven I. Rosenfeld, M.D., 561-498-8100
16201 Military Trail
Delray Beach, FL 33484